Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TapImmune Inc (NASDAQ:TPIV)

2.65
Delayed Data
As of 4:00pm ET
 +0.01 / +0.38%
Today’s Change
2.61
Today|||52-Week Range
5.35
-31.70%
Year-to-Date
No recent news for TapImmune Inc.

Today’s Trading

Previous close2.64
Today’s open2.64
Day’s range2.62 - 2.73
Volume26,250
Average volume (3 months)30,395
Market cap$27.8M
Dividend yield--
Data as of 4:00pm ET, 11/20/2017

Growth & Valuation

Earnings growth (last year)+92.31%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...+0.09+5.56%
CBLICleveland Biolabs In...+0.16+6.95%
VKTXViking Therapeutics ...-0.02-0.72%
SLNOSoleno Therapeutics ...-0.01-0.66%
Data as of 4:00pm ET, 11/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$2.5M
Net profit margin--

Profile

Sector
Consumer Services
Industry
Other Consumer Services
President, Chief Executive Officer &
Director
Peter L. Hoang
Chief Financial Officer, Secretary &
Treasurer
Michael J. Loiacono
Corporate headquarters
Jacksonville, Florida

Forecasts